Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03985020 · ClinicalTrials.gov registry record · NA
Super HEROES: Searching How the Extract Rebaudioside Occludes Excess Steatosis
A NA study, sponsored by Children's Hospital Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT03985020 is a NA study that has completed, run by Children's Hospital Los Angeles. The registered enrollment target is 20 participants.
The verdict
NCT03985020, a NA study, has completed, sponsored by Children's Hospital Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
In order to determine whether rebaudioside consumption can be used as a treatment for adolescents with Non-alcoholic Fatty Liver Disease (NAFLD) by demonstrating a decrease in alanine aminotransferase (ALT) levels participants will be randomized to receive one of three 8-week liquid diet interventions: 1. Standard of care 2. Water delivery 3. Water with Rebaudioside (stevia natural sweetener)
Interventions
- OTHER Stevia Intervention
- OTHER Water Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-07-26 |
| Est. Completion | 2024-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03985020
The ClinicalTrials.gov registry entry for NCT03985020 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Los Angeles, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Stevia Intervention is the first listed.
NCT03985020 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03985020 about?
NCT03985020 is a clinical study titled "Super HEROES: Searching How the Extract Rebaudioside Occludes Excess Steatosis". In order to determine whether rebaudioside consumption can be used as a treatment for adolescents with Non-alcoholic Fatty Liver Disease (NAFLD) by demonstrating a decrease in alanine aminotransferase (ALT) levels participants will be randomized to receive one of three 8-week liquid diet interventio...
What is the current status of trial NCT03985020?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2019-07-26. Estimated completion is 2024-08-01.
What interventions are being tested in trial NCT03985020?
The interventions under investigation include: Stevia Intervention (OTHER), Water Intervention (OTHER).
Who is sponsoring clinical trial NCT03985020?
This trial is sponsored by Children's Hospital Los Angeles, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.